Capricor Therapeutics, Inc. (CAPR) vs ARS Pharmaceuticals, Inc. (SPRY)
- Capricor Therapeutics, Inc. CAPR 6.71 −7.70%
- ARS Pharmaceuticals, Inc. SPRY 4.02 −1.23%
Capricor Therapeutics, Inc. and ARS Pharmaceuticals, Inc. are both Biotechnology companies. Capricor Therapeutics, Inc. and ARS Pharmaceuticals, Inc. are of similar size ($422.7M and $404.8M). ARS Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 4.08% against −11.6%. Capricor Therapeutics, Inc. has the higher net margin (0.00% vs −184.3%) and the lower return on invested capital (−1,019.7% vs −335.7%). Across the 17 metrics below, Capricor Therapeutics, Inc. leads on 12 and ARS Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | CAPR | SPRY | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 71.37% | 65.16% |
| Operating margin | 0.00% | (184.96%) | 0.00% |
| Net margin | 0.00% | (184.26%) | 0.00% |
| Free cash flow margin | 0.00% | (167.97%) | 0.00% |
| Return on equity | (73.70%) | (210.37%) | (56.36%) |
| Return on assets | (51.53%) | (76.54%) | (48.04%) |
| Return on invested capital | (1,019.73%) | (335.65%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack